.
ResMed’s Inc (ASX:RMD) profit rose nine per cent in its first quarter, buoyed by revenue growth and widening margins.
However, that result missed analysts’ expectations.
For the quarter ended September 30, ResMed posted a profit of $80.9 million, up from $71.3 million, in the previous corresponding period.
Revenue rose 5 per cent to $357.7 million.
ResMed develops products for the treatment of respiratory disorders, including flow generators and humidifiers.
ResMed delivered a net profit of $331 million in fiscal 2013.
{"streaming_server":"rtmp:\/\/s2svek4dh1hfyu.cloudfront.net\/cfx\...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
